EFFICACY AND TOLERABILITY OF GENERIC ZOLEDRONIC ACID 5 MG (REZOCLASTIN PS) IN THE TREATMENT OF OSTEOPOROSIS: A RETROSPECTIVE ANALYSIS OF CLINICAL EXPERIENCE WITH THE DRUG IN RUSSIA

by L A Marchenkova, A V Dreval, I V Baharev
Published 2014-12-01

ZOLEDRONIC ACID IN THE TREATMENT OF OSTEOPOROSIS AND OTHER SKELETAL DISORDERS

by S Yu Vorotnikova, E A Pigarova
Published 2016-12-01

TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS WITH NITROGEN CONTAINING BISPHOSPHONATES, EARLY SIDE EFFECTS AND THEIR PREVENTION

by O V Yakushevskaya, S V Yureneva
Published 2013-12-01

PATOGENETIChESKIE OSNOVY RAZVITIYa OSTROY FAZY OTVETA NA VNUTRIVENNOE VVEDENIE AZOTSODERZhAShchIKh BISFOSFONATOV

by O V YaKUShEVSKAYa, S V YuRENEVA
Published 2014-12-01

EFFECT OF ZOLEDRONIC AND IBANDRONIC ACIDS ON BONE METABOLISM IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS

by O V Yakushevskaya, E V Bordakova, A A Gavisova, S Yu Kuznetsov, S V Yureneva, T Yu Ivanets, V P Smetnik, G T Sukhikh
Published 2012-08-01

Primenenie Zomety na fone endokrinnoy terapii Femaroy u bol'nykh rakom molochnoy zhelezy s metastazami v kosti

by M M Konstantinova, L K Ovchinnikova, N N Lomakin, M G Galleev, E Sh Neretina, G Z Mukhamedshina, F Kh Mukhametgaleeva
Published 2007-06-01

ATYPICAL FRACTURES DUE TO LONG TREATMENT WITH BISPHOSPHONATES (CRITICAL REVIEW)

by G. S. Golubev
Published 2013-03-01